文献速递消化内镜消化道肿瘤与早癌

结肠镜检查中黏膜暴露装置联合计算机辅助检测提高腺瘤检出率:一项随机试验

Combination of Mucosa-Exposure Device and Computer-Aided Detection for Adenoma Detection During Colonoscopy: A Randomized Trial.
PubMed 文献 · Gastroenterology · 2023-04-14

在意大利和瑞士6个中心开展的多中心随机试验中,1316例接受结肠镜检查的患者被1:1分配至计算机辅助检测(CADe)联合黏膜暴露装置(ECV)组或单独CADe组。联合组腺瘤检出率显著高于对照组(49.6% vs 44.0%),每例结肠镜检查检出腺瘤数也显著更高,而退镜时间和不必要息肉切除术比例无显著差异。

要点

  • CADe联合ECV组腺瘤检出率49.6%,显著高于单独CADe组的44.0%。
  • 联合组每例结肠镜检查检出腺瘤数显著高于对照组(0.94 vs 0.74)。
  • 两组晚期腺瘤和锯齿状病变检出率无显著差异。

核心结论

  • 与单独CADe辅助结肠镜相比,CADe联合ECV可提高腺瘤检出率和每例结肠镜检查检出的腺瘤数,且不增加退镜时间。

研究设计与样本

  • 多中心随机试验,在意大利和瑞士6个中心纳入因结直肠癌筛查、息肉监测或临床指征接受结肠镜检查的男性和女性,1:1随机分配至CADe(GI-Genius;Medtronic)联合黏膜暴露装置(Endocuff Vision [ECV];Olympus)组或单独CADe辅助结肠镜对照组。
  • 从2021年7月1日至2022年5月31日,共1316例受试者随机分组并纳入分析,其中ECV组660例,对照组656例。
  • 所有检出的病变均被切除并送组织病理学诊断。

主要发现

  • 腺瘤检出率(至少1个组织学证实的腺瘤或癌的患者百分比)ECV组为49.6%,对照组为44.0%(相对风险,1.12;95%CI,1.00-1.26;P=.04)。
  • 每例结肠镜检查检出腺瘤数ECV组为0.94±0.54,对照组为0.74±0.21(发生率比,1.26;95%CI,1.04-1.54;P=.02)。
  • 两组在晚期腺瘤和锯齿状病变检出方面无差异。
  • 平均退镜时间ECV组为9.01±2.48秒,对照组为8.96±2.24秒(P=.69);接受不必要息肉切除术(息肉切除但无组织学证实的腺瘤)的受试者比例相对风险为0.89(95%CI,0.69-1.14;P=.38),两组无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Both computer-aided detection (CADe)-assisted and Endocuff-assisted colonoscopy have been found to increase adenoma detection. We investigated the performance of the combination of the 2 tools compared with CADe-assisted colonoscopy alone to detect colorectal neoplasias during colonoscopy in a multicenter randomized trial. METHODS: Men and women undergoing colonoscopy for colorectal cancer screening, polyp surveillance, or clincial indications at 6 centers in Italy and Switzerland were enrolled. Patients were assigned (1:1) to colonoscopy with the combinations of CADe (GI-Genius; Medtronic) and a mucosal exposure device (Endocuff Vision [ECV]; Olympus) or to CADe-assisted colonoscopy alone (control group). All detected lesions were removed and sent to histopathology for diagnosis. The primary outcome was adenoma detection rate (percentage of patients with at least 1 histologically proven adenoma or carcinoma). Secondary outcomes were adenomas detected per colonoscopy, advanced adenomas and serrated lesions detection rate, the rate of unnecessary polypectomies (polyp resection without histologically proven adenomas), and withdrawal time. RESULTS: From July 1, 2021 to May 31, 2022, there were 1316 subjects randomized and eligible for analysis; 660 to the ECV group, 656 to the control group). The adenoma detection rate was significantly higher in the ECV group (49.6%) than in the control group (44.0%) (relative risk, 1.12; 95% CI, 1.00-1.26; P = .04). Adenomas detected per colonoscopy were significantly higher in the ECV group (mean ± SD, 0.94 ± 0.54) than in the control group (0.74 ± 0.21) (incidence rate ratio, 1.26; 95% CI, 1.04-1.54; P = .02). The 2 groups did not differ in term of detection of advanced adenomas and serrated lesions. There was no significant difference between groups in mean ± SD withdrawal time (9.01 ± 2.48 seconds for the ECV group vs 8.96 ± 2.24 seconds for controls; P = .69) or proportion of subjects undergoing unnecessary polypectomies (relative risk, 0.89; 95% CI, 0.69-1.14; P = .38). CONCLUSIONS: The combination of CADe and ECV during colonoscopy increases adenoma detection rate and adenomas detected per colonoscopy without increasing withdrawal time compared with CADe alone. CLINICALTRIALS: gov, Number: NCT04676308.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Spadaccini M, Hassan C, Rondonotti E, et al. Combination of Mucosa-Exposure Device and Computer-Aided Detection for Adenoma Detection During Colonoscopy: A Randomized Trial. Gastroenterology. 2023. PMID: 37061169. doi:10.1053/j.gastro.2023.03.237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。